Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
It marks the second COVID-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.
Prior to the approvals, both vaccines have already been used in China's vaccination program mainly targeting key groups deemed to be at higher risk of exposure to the virus.
Indonesia, Turkey, Brazil, Chile, Colombia, Uruguay, and Laos have granted emergency authorizations for the CoronaVac vaccine developed by Sinovac Life Sciences, Sinovac said in a news release.
The approval is based on the two-month results from late-stage clinical trials overseas, from which the final analysis data has not yet been obtained, Sinovac said.
Trump says US destroyed mine-laying vessels after warning Iran
Britain working with allies to support shipping through Strait of Hormuz
Five Iranian women's soccer players granted humanitarian visas in Australia
Almost 700,000 displaced after Israeli strikes on Lebanon, UN agencies say
Iran fighting back but not stronger than U.S. thought, top U.S. general says
British warship HMS Dragon departs for Eastern Mediterranean
One dead, several injured in Iranian attack on Manama building
Russian drones injure 20 in Ukraine's Kharkiv, Dnipro
